third seminar- Methods based on antigen-antibody interaction (ELISA, RIA, IRMA, ELISPOT, immunohistochemistry, Western blot, ELFA, lateral flow tests) Flashcards
Epitope variants
conformational determinants, where denaturation destroys the conformation the epitope had subsequently no more binding occurs.
linear epitope- binding is either allowed in its natural conformation and/or when its denatured
neoantigenic determinant where a new antigen is formed with proteloysis
Different methods use different epitopes recognizing antibodies for the same antigen to detect.
What is a immunogenic carrier?? (not sure about name)
Haptens are small molecules that elicit an immune response only when attached to a large carrier such as a protein; the carrier may be one that also does not elicit an immune response by itself. (In general, only large molecules, infectious agents, or insoluble foreign matter can elicit an immune response in the body.) Once the body has generated antibodies to a hapten-carrier adduct, the small-molecule hapten may also be able to bind to the antibody, but it will usually not initiate an immune response; usually only the hapten-carrier adduct can do this.
Generation of polyclonal antibodies with haptan+carrier produces??
Antibodies against the haptan, against the carrier molecules and against the haptan+carrier molecules.
Generation of monoclonal Abs by hybridoma techniques
too lazy to copy, teacher emphasized this as a favorite question in the exam
1) Immunization
2) B cell isolation from spleen
(3) Culture of myeloma cells
(4) Fusion of myeloma cells and B cells
(5) Cloning (separation of the different cell lines) (8) Isolation of antibodies
Immunoglobulins can be conjugated covalently to marker molecules
Marker and its uses?
Not sure how relevent this is but thought it might be nice as a review.
fluorochromeImmunocytochemistry Enzyme Elisa, elispot, immunoblot biotin indirect immunocytochemistry colloid gold electron microscopic immunocytochemistry radioactive isotope RIA, IRMA, RRA
avidin, streptavidin, biotin???
Biotin (B7) is bound to antibody and avidin/ streptavidin bind to biotin,serves as a basis of several test systems.
Statisctical features of diagnostic methods
Sensitivity: is reflects how sensitive the antibody is, what % of the patients samples are recognized as „positive” ones
Specificity: the % of healthy samples tested as „negative”
which methods.. blah blah..
METHODS
Biological body fluid sample – ELISA, RIA, IRMA, LATERAL FLOW
Isolated cells - ELISPOT
Biological solid tissue section– IMMUNOHYSTOCHEMISTRY
Isolated proteins - WESTERN BLOT
Elisa- indirect
TO DETECT ANTIBODY
Indirect ELISA is a two-step ELISA which involves two binding process of primary antibody and labeled secondary antibody. The primary antibody is incubated with the antigen followed by the incubation with the secondary antibody. However, this may lead to nonspecific signals because of cross-reaction that the secondary antibody may bring about.
- Micro-well plates are incubated with antigens, washed up and blocked with BSA.
- Samples with antibodies are added and washed.
- Enzyme linked secondary antibody are added and washed.
- A substrate is added, and enzymes on the antibody elicit a chromogenic or fluorescent signal.
***Direct elisa just uses a primary antibody only allowing a fast detection
sandwich elisa
To detect antigen
(1) Plate is coated with a capture antibody;
(2) sample is added, and any antigen present binds to capture antibody;
(3) detecting antibody is added, and binds to antigen; (4) enzyme-linked secondary antibody is added, and binds to detecting antibody;
(5) substrate is added, and is converted by enzyme to detectable form.
THE DETECTING ANTIBODY IS OF PRIMARY ORIGIN AND NOT SECONDARY LIKE INDIRECT!!!
Competitive ELISA
More sensitive in low concentration range.
The antigen present in the sample, binds to the antibodies, and thus, it inhibits their binding to the purified antigen coated onto a solid surface of the ELISA plate.
1) Primary antibody (unlabeled) is incubated with sample antigen.
2) Antibody-antigen complexes are then added to 96-well plates which are pre-coated with the same antigen
A bit more about this step… Serum is mixed with another tube holding a certain amount of known antibodies against HIV antigens for this example.
Then we add this sample to the well (containing bound complexes and unbound complexes incase theres low amount of HIV or none at all)
3) Unbound antibody is removed by washing the plate. (Since they are bound to the antigens from the sample before)
The more antigen in the sample, the less antibody will be able to bind to the antigen in the well, hence “competition.
This means that if the person is infected he will not have binding antibodies to the well since they will all be occupied before adding them to the well!!
4) The secondary antibody that is specific to the primary antibody and conjugated with an enzyme is added.
A substrate is added, and remaining enzymes elicit a chromogenic or fluorescent signal.
For competitive ELISA, the higher the sample antigen concentration, the weaker the eventual signal. The major advantage of a competitive ELISA is the ability to use crude or impure samples and still selectively bind any antigen that may be present.
Example for a routine ELISA test result (rheumatoid factor)
Rheumatoid factor (anti IgG antibody) detected by an IGM
generaly elisa can be used in autoimmune diagnostics, endocrinology, microbiology and tumor diagnostics.
Elispot
The Enzyme-Linked ImmunoSpot (ELISPOT) assay is a widely used method for monitoring cellular immune responses.
The ELISPOT technique has proven to be useful means available for monitoring cell-mediated immunity, due to its sensitive and accurate detection of rare antigen-specific T cells (or B cells) and its ability to visualize single positive cells within a population of peripheral blood mononuclear cells (PBMCs).
It is an indirect immunoassay in which we can detect molecules (most often cytokines) secreted by
individual cells.
- The wells of the special 96 well ELISPOT plates have either nitrocellulose or PVDF membrane bottom that is coated under sterile conditions with a capture antibody.
- Next we block the free protein binding surfaces by incubating the surfaces with a buffer containing an indifferent protein (such as bovine serum albumin).
- This is followed by pipetting live cells (e.g. 1-300,000 lymphocytes) into the wells, and incubating them.
4.Then we wash the cells out of the wells, and the
secreted molecules bound to the capture antibody are
visualized by using a labeled secondary antibody and a
substrate that will form an insoluble precipitate.
5.After drying the plate, we analyze the scanned spots
at the bottom of the wells with image analyzer
software.
Example for use of ELISA and ELISPOT in the routine clinical practice
to diagnose for latent tuberculosis infection
Mycobacterium tuberculosis infection induces a cellular immune response
Activated T-lymphocytes release interferon-gamma
During infection memory T-cells arise, tests measure their rapid IFN-gamma release upon antigen contact
ELISA based QuantiFERON test
ELISPOT-based T-Spot test
QuantiFERON, also known as QFT, is the registered trademark of the test for tuberculosis infection or latent tuberculosis. QFT is an interferon-γ release assay (IGRA) used in tuberculosis diagnosis.
Method:
1 ml of blood
Into each of three tubes: incubated with three TB antigen peptides
Released IFN-g amount in harvested plasma is measured by ELISA method.
Result within 24 hours
Requires no specific laboratory background
ELISPOT-based
T-Spot test
Separated PBMC are kept alive under sterile conditions on a coated ELISPOT plate
Incubated with two TB antigens
Released IFN-g amount is measured after washing off cells
Result within 24 hours
Requires specific cell culture conditions